First-line combined Checkpoint Blockade in Patents with MSI-H/dMMR mCRC

被引：0
|
作者：
Klein, Friederike
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2022年 / 60卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：562 / 562
页数：1
相关论文
共 50 条
  • [21] Impact of antibiotic exposure on the efficacy of immune checkpoint blockade in MSI-H metastatic CRC
    Serpas, Victoria
    Rogers, Jane Elizabeth
    Xiao, Lianchun
    Mola-Rudd, Kerri
    Dasari, Arvind
    Kee, Bryan K.
    Overman, Michael J.
    Johnson, Benny
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [22] Neoadjuvant pembrolizumab shows promise in MSI-H/dMMR solid tumours
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (03) : 138 - 138
  • [23] The clinical and genomic characteristics of MSI-h/dMMR lung cancer.
    Qin, Jianwen
    Shi, Dongsheng
    Yin, Yan
    Bin Liu
    Wang, Lei
    Sun, Tingting
    Zhang, Qin
    Qi, Chuang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] IVOLUMAB PLUS IPILIMUMAB ACHIEVES RESPONSES IN DMMR/MSI-H TUMORS
    不详
    CANCER DISCOVERY, 2018, 8 (03) : 263 - 263
  • [25] Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
    Ambrosini, Margherita
    Manca, Paolo
    Nasca, Vincenzo
    Sciortino, Carolina
    Ghelardi, Filippo
    Seligmann, Jenny F.
    Taieb, Julien
    Pietrantonio, Filippo
    NATURE REVIEWS CLINICAL ONCOLOGY, 2025,
  • [26] Response to first-line platinum chemotherapy in microsatellite instability high (MSI-H) metastatic endometrial carcinoma
    Colomba, E.
    Alexandre, J.
    Le Teuff, G.
    Coupez, D.
    Genestie, C.
    Ray-Coquard, I. L.
    Brachet, P. E.
    Sajous, C.
    De Percin, S.
    Fabbro, M.
    Delanoy, N.
    Joly, F.
    Pautier, P.
    Frenel, J-S.
    Leary, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S763 - S763
  • [27] MSI-H/dMMR and cancer immunotherapy: current state and future implications
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Gadaleta-Caldarola, Gennaro
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (06): : 345 - 347
  • [28] COMPANION DIAGNOSTIC ASSAYS FOR PEMBROLIZUMAB IN PATIENTS WITH MSI-H/DMMR TUMORS
    Marabelle, Aurelien
    Cesario, Jeff
    Lang, Lixin
    Aurora-Garg, Deepti
    Mathur, Siddhartha Krishan
    Levitan, Diane
    Card, Deb
    Jin, Fan
    Adelberg, David
    Andre, Thierry
    Wehn, Amy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A569 - A569
  • [29] Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
    Margalit, Ofer
    Stemmer, Amos
    Chapin, William J.
    Shacham-Shmueli, Einat
    Kopetz, Scott
    Andre, Thierry
    Overman, Michael J.
    Pietrantonio, Filippo
    Boursi, Ben
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [30] Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
    Mulet-Margalef, Nuria
    Linares, Jenniffer
    Badia-Ramentol, Jordi
    Jimeno, Mireya
    Monte, Carolina Sanz
    Mozo, Jose Luis Manzano
    Calon, Alexandre
    CANCERS, 2023, 15 (04)
12345